Your browser doesn't support javascript.
loading
BCG-Induced Tumor Immunity Requires Tumor-Intrinsic CIITA Independent of MHC-II.
Redelman-Sidi, Gil; Binyamin, Anna; Antonelli, Anthony C; Catalano, Will; Bean, James; Al-Ahmadie, Hikmat; Jungbluth, Achim A; Glickman, Michael S.
Afiliação
  • Redelman-Sidi G; Division of Infectious Diseases, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Binyamin A; Immunology Program, Sloan Kettering Institute, New York, New York.
  • Antonelli AC; Immunology Program, Sloan Kettering Institute, New York, New York.
  • Catalano W; Immunology and Microbial Pathogenesis, Weill Cornell Medicine Graduate School of Medical Sciences, New York, New York.
  • Bean J; Immunology Program, Sloan Kettering Institute, New York, New York.
  • Al-Ahmadie H; Immunology Program, Sloan Kettering Institute, New York, New York.
  • Jungbluth AA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Glickman MS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer Immunol Res ; 10(10): 1241-1253, 2022 10 04.
Article em En | MEDLINE | ID: mdl-36040405
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Receptor de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Receptor de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article